Literature DB >> 29385877

Psychiatric disorders in patients with intractable dizziness in the department of otolaryngology.

Fumiyuki Goto1, Nagisa Sugaya2, Miki Arai1, Kanako Masuda1.   

Abstract

OBJECTIVE: Vertigo and dizziness are often not fully explained by organic illnesses, but instead may be related to psychiatric disorders. It is important to determine the types of psychiatric comorbidities that are frequent in cases of intractable dizziness.
METHOD: The study subjects were 90 patients who had experienced intractable dizziness for more than three months and were referred to a psychiatrist when their symptoms could not be fully explained based on their physical illness. The patients' final diagnosis and questionnaire (DHI,SDS and STAI) scores were evaluated.
RESULTS: Seventy percent (63/90) of patients with intractable dizziness had been diagnosed as having psychiatric conditions by the study psychiatrists. The most common diagnosis was unspecified depressive disorder.
CONCLUSIONS: Psychiatric comorbidities seem to be more prevalent in certain subgroups of organic dizziness. We found a higher rate of depressive disorders in the sequelae of sudden deafness and migraine-related dizziness.

Entities:  

Keywords:  Chronic dizziness; anxiety disorders; comorbid disorder; depression; sudden deafness

Mesh:

Year:  2018        PMID: 29385877     DOI: 10.1080/00016489.2018.1429652

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Correlation Between the Prognosis of Sudden Total Deafness and the Peripheral Blood Inflammation Markers.

Authors:  Tongxiang Diao; Yujie Ke; Junbo Zhang; Yuanyuan Jing; Xin Ma
Journal:  Front Neurol       Date:  2022-06-15       Impact factor: 4.086

2.  Depression scores and quality of life of vertiginous patients, suffering from different vestibular disorders.

Authors:  András Molnár; Stefani Maihoub; Panayiota Mavrogeni; László Tamás; Ágnes Szirmai
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-04-18       Impact factor: 3.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.